Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

Share Price is delayed by 15 minutes
Get Live Data
16.45    0.00 (0.00%)
Bid:
16.45
Ask:
16.80
Spread: 0.35 (2.128%)
Market Cap: £131.85m
ALL Live PriceLast checked at - London Stock Exchange

Intraday Atlantic Lithium Share Chart

Trading Update

16 Dec 2013 07:00

RNS Number : 5658V
Allocate Software PLC
16 December 2013
 



16 December 2013

 

ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

 

First Half Trading Update

 

Allocate Software plc (AIM: ALL), the leading provider of workforce and compliance optimisation solutions, reports the following update for the six months ended 30 November 2013.

 

Allocate's performance in the first half year is in line with the Board's expectations, with total revenue, recurring revenue and pipeline growing versus the first half of the prior year, in what remains the seasonally slower period of our financial year.

 

Closing net cash has risen to £7.4m versus £2.1m at half year end of the prior year.

 

Healthroster continues to lead our business with a better than expected performance in the period. We secured an additional four new customers, including three new NHS Trusts taking the total to 154. These three wins included two competitive displacements. In addition, we renewed a further ten Healthroster term licence customers, bringing the total now to 43 and maintaining our 100% renewal rate.

 

The adoption of the Allocate Cloud continues to increase and is in line with our target of doubling the number of Cloud customers by the end of this financial year.

 

Our latest application, Safe Care, has been well received by NHS Trusts with a number of customers agreeing contracts in the period.

Our Patient Flow and Emergency Department business has not grown at the speed that management expected. Whilst the product has been well received by a number of potential customers, decision cycles are longer than expected.

Our Swedish business continues to perform ahead of management's plans and our Australia business has met expectations, in terms of results and also pipeline. Maritime and Defence had a first half focused primarily on business development activities, as expected.

 

We are pleased to have concluded the rationalisation of our London premises to a single head office and the relocation of our Swedish subsidiary's main office in the period. An exceptional cost will be recorded in the period in respect of these moves.

 

The Company's results for the half year to 30 November 2013 will be released on 20 January 2014.

 

Ian Bowles, Chief Executive Officer of Allocate, commented:

 

"The first half saw another solid performance from Allocate.

 

The demand for our productsremains healthy, particularly with respect to HealthRoster, the Allocate Cloud and Safe Care. We exited the half year with a larger pipeline for these solutions than we had at the beginning of this financial year and significantly stronger than at the same time last year.

 

The focus of the Secretary of State for Health, NHS England and the Care Quality Commission on safe staffing is a key driver of the increasing number of Trusts expressing interest in our solutions, particularly Safe Care.

 

I expect the positive trend we are seeing to continue through the second half of this year. The transition of our customer base onto V10 is a key requirement for growth in sales of Safe Care and Cloud and I am pleased to report that this program continues to be on track.

 

Although the timing of our licence and services revenues remains weighted to the latter part of the year, our strong product portfolio, sales pipeline and the improving quality of our revenue streams give us confidence in a strong second half performance."

 

Enquiries:

 

Allocate Software plc

Ian Bowles - Chief Executive Officer

Chris Gale - Chief Financial Officer

Martin Jeffries - Marketing Director

 

Tel: +44 (0) 20 7355 5555

Numis Securities

Nominated adviser - Simon Willis / Richard Thomas

Corporate Broking - James Black

 

Tel: +44 (0) 20 7260 1000

FTI Consulting

Matt Dixon, Chris Lane

Tel : +44 (0) 20 7831 3113

 

 

About Allocate Software plc

Allocate Software is the leading workforce and corporate governance software solutions provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include Healthcare and Defence.

 

The experience and in-depth knowledge gained in the UK and internationally has enabled Allocate to invest in developing innovative solutions that are relevant to the constantly evolving market needs of its customers. At the core of the business is Allocate's workforce optimisation software, which streamlines the whole workforce management of multi-disciplinary groups, across diverse locations.

 

Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA, Australia and Malaysia.

 

Allocate is quoted on the London Stock Exchange (AIM: ALL).

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUOUWROAAUAAA
Date   Source Headline
11th May 20267:00 amRNSElevra to Transfer Ewoyaa Rights and Obligations
7th May 20267:00 amRNSBinding Scheme Implementation Deed with Huayou
30th Apr 20267:00 amRNSQuarterly Activities and Cash Flow Report
20th Mar 20263:00 pmRNSTR-1 Notification of Major Holdings
20th Mar 20267:00 amRNSParliamentary Ratification of Ewoyaa Mining Lease
17th Mar 20261:03 pmRNSCorporate Funding Update - Amendment
17th Mar 20267:00 amRNSCorporate Funding Update
17th Mar 20267:00 amRNSCorporate Funding Update
13th Mar 20267:09 amRNSHalf-year Financial Report
13th Mar 20267:09 amRNSHalf-year Financial Report
23rd Feb 20267:00 amRNSCorporate Update
19th Feb 20268:27 amRNSASX Trading Halt
29th Jan 20267:00 amRNSQuarterly Activities and Cash Flow Report
22nd Dec 20257:00 amRNSRatification Process - Ewoyaa Mining Lease
22nd Dec 20257:00 amRNSRatification Process - Ewoyaa Mining Lease
11th Dec 20257:05 amRNSDirector/PDMR Dealings
11th Dec 20257:00 amRNSUpdate re the Ewoyaa Mining Lease
3rd Dec 20257:00 amRNSTR-1 Notification of Major Holdings
27th Nov 20259:25 amRNSResult of Annual General Meeting
27th Nov 20257:05 amRNSAGM Statement
27th Nov 20257:00 amRNSWithdrawal of AGM Resolution
26th Nov 20257:00 amRNSLong State Funding Update
12th Nov 20257:00 amRNSEwoyaa Lithium Project - Mining Lease Update
6th Nov 202510:07 amRNSResult of Extraordinary General Meeting
31st Oct 20257:00 amRNSQuarterly Activities and Cash Flow Report
28th Oct 20257:00 amRNSNotice of Annual General Meeting
20th Oct 20257:00 amRNSPronounced Lithium-in-soil Anomalies
7th Oct 20257:28 amRNSNotice of Extraordinary General Meeting
11th Sep 20257:00 amRNS2025 Annual Financial Report
9th Sep 20257:00 amRNSTR-1 Notification of Major Holdings
3rd Sep 20257:00 amRNSCorporate Funding Update
31st Jul 20257:00 amRNSQuarterly Activities and Cash Flow Report
18th Jul 20257:00 amRNSEwoyaa Lithium Project - Mining Lease Update
11th Jun 20257:00 amRNSLeadership Streamlining and Cost Reductions
22nd May 20257:00 amRNSSpodumene Pegmatite Discovered in Côte d’Ivoire
19th May 20257:00 amRNSLapse of PDMR Options
30th Apr 20257:00 amRNSQuarterly Activities and Cash Flow Report
24th Apr 202511:56 amRNSResponse to Media Reporting
4th Apr 20257:00 amRNSLapse of PDMR Options
14th Mar 20257:00 amRNSHalf-year Financial Report
4th Feb 20254:06 pmRNSResponse to Press Speculation
30th Jan 20257:15 amRNSQuarterly Activities and Cash Flow Report
30th Jan 20257:00 amRNSUpdated Ewoyaa Feldspar Resource Estimate
24th Jan 20257:00 amRNSResignation of Non-Executive Director
23rd Dec 20247:00 amRNSGrant of Performance Rights
16th Dec 20247:00 amRNSTR-1 Notification of Major Holdings
10th Dec 20247:00 amRNSIssue of Equity
29th Nov 20247:51 amRNSResult of AGM
29th Nov 20247:00 amRNSAGM Statement
26th Nov 20247:00 amRNSStatement re Proposed Merger of PLL and SYA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.